학술논문

Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial
Document Type
Article
Source
In Molecular Therapy 5 July 2023 31(7):2077-2088
Subject
Language
ISSN
1525-0016